Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up
Intravitreal aflibercept using a TAE regimen improved visual and anatomical outcomes of patients with type 1 CNV secondary to chronic CSC in long-term follow-up. Naive patients had a better visual outcome and a higher incidence of complete fluid resolution than PDT-treated patients.
Authors
- А. О. Невська
- N. Pasyechnikova (ORCID: https://orcid.org/0000-0001-5718-8700)
- A. Korol (ORCID: https://orcid.org/0000-0003-0516-308X)
- Taras Kustryn (ORCID: https://orcid.org/0000-0003-2334-6728)
- O. Zadorozhnyy (ORCID: https://orcid.org/0000-0003-0125-2456)
- I. Nasinnyk (ORCID: https://orcid.org/0000-0002-1717-5777)
- Ксенія Трояновська
Institutions
- Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine (UA)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.2147/opth.s532424
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00